Patent: 9,587,239
✉ Email this page to a colleague
Summary for Patent: 9,587,239
Title: | Methods of identifying and treating glioblastoma |
Abstract: | The invention encompasses methods and kits used in the detection of invasive glioblastoma based upon the expression of NHERF-1. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome. |
Inventor(s): | Kislin; Kerri L. (Phoenix, AZ), Berens; Michael Edward (Phoenix, AZ) |
Assignee: | The Translational Genomics Research Institute (Phoenix, AZ) |
Application Number: | 14/629,431 |
Patent Claims: | see list of patent claims |
Details for Patent 9,587,239
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | AVASTIN | bevacizumab | Injection | 125085 | 02/26/2004 | ⤷ Try a Trial | 2028-10-30 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |